Kestra Medical Technologies, Ltd. (KMTS)

KMTS Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2023	FY 2022	FY 2020	FY 2019
Period Ending	Oct 31, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2021	Apr 30, 2020
Net Income	-137.32	-113.81	-94.12	-	-34.1	-29.47
Depreciation & Amortization	8.02	7.97	11.56	-	0.42	0.48
Stock-Based Compensation	41.06	24.27	1.49	-	1.86	0.7
Other Adjustments	11.1	10.17	4.95	-	1.94	0
Change in Receivables	-8.98	-8.78	-2.5	-	-	-
Changes in Inventories	-2.79	-3.44	-1.18	-	-	-
Changes in Accounts Payable	0.04	2.84	7.34	-	-0.13	-0.79
Changes in Accrued Expenses	4.46	4.62	0.37	-	2.11	-0.77
Changes in Other Operating Activities	-1.93	-1.44	-0.15	-	-2	-0.45
Operating Cash Flow	-85.17	-77.61	-72.24	-69.64	-29.9	-30.29
Capital Expenditures	-26.57	-22.94	-12.23	-	-0.34	-0.23
Sale of Property, Plant & Equipment	-	-	-	-	0	-
Other Investing Activities	-0.31	-0.37	-0	-	-	-
Investing Cash Flow	-26.88	-23.31	-12.23	-15.46	-0.33	-0.23
Long-Term Debt Issued	-	-	45	-	20	-
Long-Term Debt Repaid	-	-	-39.12	-	-	-
Net Long-Term Debt Issued (Repaid)	-	-	5.88	-	20	-
Issuance of Common Stock	232.89	235.26	-	-	30.33	30.42
Net Common Stock Issued (Repurchased)	232.89	235.26	-	-	30.33	30.42
Issuance of Preferred Stock	103.4	103.4	75	-	-	-
Net Preferred Stock Issued (Repurchased)	103.4	103.4	75	-	-	-
Other Financing Activities	-3.33	-8.4	-3.15	-	-1.52	-0.18
Financing Cash Flow	378.88	330.26	77.73	96.11	48.82	30.24
Net Cash Flow	266.83	229.35	-6.74	11	18.59	-0.29
Free Cash Flow	-111.74	-100.54	-84.46	-69.64	-30.23	-30.53
FCF Margin	-150.47%	-168.09%	-303.66%	-912.74%	-	-
Free Cash Flow Per Share	-3.04	-4.09	-4.25	-658.19	-	-
Levered Free Cash Flow	-156.62	-138.53	-89.24	-86.74	-14.04	-31.23
Unlevered Free Cash Flow	-148.4	-118.9	-79.36	-80.44	-32.82	-31.23

Updated Dec 11, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q